Time Trends (2012-2020), Sex Differences and Predictors for Influenza Vaccination Uptake Among Individuals with Chronic Obstructive Pulmonary Disease in Spain

Overview

Journal J Clin Med

Specialty General Medicine

Date 2022 Mar 10

PMID 35268514

Authors

Marta Fuentes-Alonso

Rodrigo Jimenez-Garcia

Ana Lopez-de-Andres

Jose J Zamorano-Leon

David Carabantes-Alarcon

Isabel Jimenez-Trujillo

Sara Sanz-Rojo

Javier de Miguel-Diez

Affiliations

Soon will be listed here.

Abstract

(1) Background: To analyze time trends, sex differences, and factors associated with influenza vaccination uptake among individuals with COPD in Spain, 2012−2020. (2) Methods: A cross-sectional study based on data from the European Health Surveys for Spain, 2020 (EHSS2020) and 2014 and from the Spanish National Health Interview Surveys for 2017 and 2012. (3) Results: The study included 65,447 participants. Prevalence of COPD was 5.9% (n = 3855). Overall, the influenza vaccination uptake among COPD patients was 57.8% versus 28.6% for those without COPD (p < 0.001). Men with COPD reported higher uptake than women in all the surveys studied. Neither the crude nor the multivariable analysis showed a significant variation change overtime for people with COPD. However, among those aged <65 years, crude uptake decreased from 2012 to 2020 (39.4% vs. 33.3%; p = 0.039). Over the entire period, men were vaccinated significantly more than women (OR 1.28; 95% CI 1.12−1.47). Among COPD participants, included in the EHSS2020, independent predictors of vaccine uptake included being male, higher age, reporting no current smoking and suffering cancer or heart disease. (4) Conclusions: In COPD patients, the influenza vaccination uptake is below desirable levels and did not improve from 2012 to 2020. Sex differences are found, with consistent and constant lower uptake among women with COPD. The observed lower uptake among COPD women and patients with unhealthy lifestyle requires increased attention.

Citing Articles

Influenza Vaccination among Multiple Sclerosis Patients during the COVID-19 Pandemic.

Hernandez-Garcia I, Garces-Redondo M, Espinosa-Rueda J, Rodriguez-Montolio J, Bengoa-Urrengoechea I, Aibar-Remon C Vaccines (Basel). 2022; 10(10).

PMID: 36298631 PMC: 9612003. DOI: 10.3390/vaccines10101766.

References

Mayo Montero E, Hernandez-Barrera V, Carrasco-Garrido P, de Miguel A, Jimenez-Garcia R . Influenza vaccination among persons with chronic respiratory diseases: coverage, related factors and time-trend, 1993-2001. Public Health. 2007; 121(2):113-21. DOI: 10.1016/j.puhe.2006.09.009. View

Rodriguez-Rieiro C, Dominguez-Berjon M, Esteban-Vasallodominguez-Berjon M, Cuadrado A, Carrasco-Garrido P, Jimenez-Garcia R . Coverage and predictors of influenza vaccine uptake among adults aged 16 to 59 years suffering from a chronic condition in Madrid, Spain. Hum Vaccin. 2011; 7(5):557-62. DOI: 10.4161/hv.7.5.14984. View

Skull S, Andrews R, Byrnes G, Kelly H, Nolan T, Brown G . Validity of self-reported influenza and pneumococcal vaccination status among a cohort of hospitalized elderly inpatients. Vaccine. 2007; 25(25):4775-83. DOI: 10.1016/j.vaccine.2007.04.015. View

Jimenez R, Larrauri A, Carrasco P, Esteban J, Gomez-Lopez L, Gil A . Influenza coverages in Spain and vaccination-related factors in the subgroup aged 50-64 years. Vaccine. 2003; 21(25-26):3550-5. DOI: 10.1016/s0264-410x(03)00425-0. View

Dios-Guerra C, Carmona-Torres J, Lopez-Soto P, Morales-Cane I, Rodriguez-Borrego M . Prevalence and factors associated with influenza vaccination of persons over 65 years old in Spain (2009-2014). Vaccine. 2017; 35(51):7095-7100. DOI: 10.1016/j.vaccine.2017.10.086. View

Adeloye D, Chua S, Lee C, Basquill C, Papana A, Theodoratou E . Global and regional estimates of COPD prevalence: Systematic review and meta-analysis. J Glob Health. 2016; 5(2):020415. PMC: 4693508. DOI: 10.7189/jogh.05.020415. View

Rabe K, Hurd S, Anzueto A, Barnes P, Buist S, Calverley P . Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2007; 176(6):532-55. DOI: 10.1164/rccm.200703-456SO. View

Jimenez-Garcia R, Arinez-Fernandez M, Garcia-Carballo M, Hernandez-Barrera V, de Miguel A, Carrasco-Garrido P . Influenza vaccination coverage and related factors among Spanish patients with chronic obstructive pulmonary disease. Vaccine. 2005; 23(28):3679-86. DOI: 10.1016/j.vaccine.2005.02.007. View

Jimenez-Garcia R, Mayo-Montero E, Hernandez-Barrera V, Sierra-Moros M, Pachon Del Amo I, Carrasco-Garrido P . Evolution of anti-influenza vaccination coverage in Spain from 1993 to 2001. Vaccine. 2005; 23(22):2844-50. DOI: 10.1016/j.vaccine.2004.11.055. View

10.

Jimenez-Garcia R, Hernandez-Barrera V, Lopez de Andres A, Jimenez-Trujillo I, Esteban-Hernandez J, Carrasco-Garrido P . Gender influence in influenza vaccine uptake in Spain: time trends analysis (1995-2006). Vaccine. 2010; 28(38):6169-75. DOI: 10.1016/j.vaccine.2010.07.029. View

11.

Coupland C, Harcourt S, Vinogradova Y, Smith G, Joseph C, Pringle M . Inequalities in uptake of influenza vaccine by deprivation and risk group: time trends analysis. Vaccine. 2007; 25(42):7363-71. DOI: 10.1016/j.vaccine.2007.08.032. View

12.

ODonnell D, Aaron S, Bourbeau J, Hernandez P, Marciniuk D, Balter M . Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease - 2007 update. Can Respir J. 2007; 14 Suppl B:5B-32B. PMC: 2806792. DOI: 10.1155/2007/830570. View

13.

Eagan T, Hardie J, Jul-Larsen A, Grydeland T, Bakke P, Cox R . Self-reported influenza vaccination and protective serum antibody titers in a cohort of COPD patients. Respir Med. 2016; 115:53-9. DOI: 10.1016/j.rmed.2016.04.008. View

14.

Trigueros J, Riesco J, Alcazar-Navarrete B, Campuzano A, Perez J . Clinical Features Of Women With COPD: Sex Differences In A Cross-Sectional Study In Spain ("The ESPIRAL-ES Study"). Int J Chron Obstruct Pulmon Dis. 2019; 14:2469-2478. PMC: 6842276. DOI: 10.2147/COPD.S217921. View

15.

Poole P, Chacko E, Wood-Baker R, Cates C . Influenza vaccine for patients with chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2006; (1):CD002733. DOI: 10.1002/14651858.CD002733.pub2. View

16.

Ford E, Williams S, Mannino D, Redd S . Influenza vaccination coverage among adults with asthma: findings from the 2000 Behavioral Risk Factor Surveillance System. Am J Med. 2004; 116(8):555-8. DOI: 10.1016/j.amjmed.2003.11.018. View

17.

Garrastazu R, Garcia-Rivero J, Ruiz M, Helguera J, Arenal S, Bonnardeux C . Prevalence of Influenza Vaccination in Chronic Obstructive Pulmonary Disease Patients and Impact on the Risk of Severe Exacerbations. Arch Bronconeumol. 2015; 52(2):88-95. DOI: 10.1016/j.arbres.2015.09.001. View

18.

Alonso Perez T, Garcia Castillo E, Ancochea J, Pastor Sanz M, Almagro P, Martinez-Camblor P . Sex differences between women and men with COPD: A new analysis of the 3CIA study. Respir Med. 2020; 171:106105. DOI: 10.1016/j.rmed.2020.106105. View

19.

Ruiz Azcona L, Roman-Rodriguez M, Llort Bove M, van Boven J, Santibanez Marguello M . Prevalence of Seasonal Influenza Vaccination in Chronic Obstructive Pulmonary Disease (COPD) Patients in the Balearic Islands (Spain) and Its Effect on COPD Exacerbations: A Population-Based Retrospective Cohort Study. Int J Environ Res Public Health. 2020; 17(11). PMC: 7312905. DOI: 10.3390/ijerph17114027. View

20.

Nichol K, Baken L, Nelson A . Relation between influenza vaccination and outpatient visits, hospitalization, and mortality in elderly persons with chronic lung disease. Ann Intern Med. 1999; 130(5):397-403. DOI: 10.7326/0003-4819-130-5-199903020-00003. View